天天酷跑唐小僧视频:Disclaimer

According to No.14 of Chapter 4 of the Measures for the Administration of Private Equity Investment Fund Raising Behavior: “Private fund managers and private equity fund sales institutions may not raise funds from organizations and individuals other than qualified investors, and may not promote to non-specific objects by public communication media such as newspapers, radio stations, televisions, the Internet or through the lectures, presentations, analysis meetings and announcements, flyers, SMS, WeChat, blogs, and e-mails."

Based on the provisions of the Measures for the Administration of Private Equity Investment Fund Raising Behavior, Cornerstone Capital will only promote and recommend relevant private equity fund products to certain qualified investors.

If you are interested in investing in private equity investment funds and meet the requirements as a qualified investor by Measures for the Administration of Private Equity Investment Fund Raising Behavior, you will have the corresponding risk identification capability and risk-taking ability. The amount invested in a single private equity fund is not Less than 1 million yuan, and personal financial assets is not less than 3 million yuan or the average annual income of individuals in the last three years is not less than 500,000 yuan. Please read this tip in detail and register as a specific qualified investor of the Cornerstone Capital to obtain the promotion and service of the private equity investment fund.

天天酷跑啵啵奇|ENGLISH
CORNERSTONE OF PROSPERITY

Stable as Cornerstone Accumulation as mountain

Focus on capital market Assist companies to boost

Company Profile

Cornerstone Capital focuses on value investing in global emerging economies areas. The investment phase spans the early, middle and late stages. And the invested industry covers TMT, biomedicine, energy conservation, environmental protection and so on. The core members of Cornerstone Capital are from top investment banks at home and abroad, involving a lot of resources to invest in domestic and overseas capital markets for more than 20 years. The leading listed financing, mergers and acquisitions and other projects are about 150 cases. Among them, there are more than 50 companies listed on the stock exchanges in the mainland China, Hong Kong, the United States, and Singapore.


As a leader in the corporate capital market, Cornerstone Capital leverages its strengths to assist companies in resolving capital markets from the Pre-ipo, cornerstone investors, new share subscriptions, private placements, block trades, mergers and acquisitions, and privatization returns. Assist companies to solve various adversities and problems in the capital market.


Exploring the Value, Investing the Future is the constant investment philosophy of Cornerstone Capital. Cornerstone Capital grasps global cyclical investment opportunities, and its products cover domestic and foreign primary and secondary markets, including equity funds, secondary market funds, and commodity futures quantitative funds. On behalf of the product, the Oriental Value Private Fund successfully withdrew from the liquidation in October 2017, and the Oriental Value Private Fund was ranked among the top three private equity yields in 2016.


  • 20Year

    Involved a lot of resources to domestic and foreign capital markets for more than 20 years.
  • 150Cases

    Leading around 150 cases in listed financing, mergers and acquisitions, etc.
  • 50Companies

    More than 50 companies have listed and trading.

Success Case

More  
  • UMRX

    Unum Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing new immunotherapeutic products designed to treat cancer using the patient's immune system. It was listed on the NASDAQ Stock Exchange in the United States , code: UMRX.

  • AIMI

    Aimmune is a clinical-stage biopharmaceutical company that is pursuing a new approach to treatment, including the development of proprietary drug candidates for the treatment of peanuts and other food allergies. It was listed on the NASDAQ Stock Exchange on August 6, 2015, code: AIMT.

  • TOCA

    Tocagen Inc. specializes in developing first-class, broadly applicable product candidates designed to activate patients' immune systems for their own cancers. It was listed on the NASDAQ Stock Exchange on April 13, 2017, code: TOCA.

  • KNSA

    Kiniksa Pharmaceuticals, Ltd. was established in Bermuda on July 21, 2015. Kiniksa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, acquisition, development and commercialization of therapeutic drugs for patients with severe unmet medical needs.

  • LOXO

    Loxo Oncology is a biopharmaceutical company that provides innovative, highly selective drugs for genotyping cancer patients. Listed on the NASDAQ Stock Exchange in the US on 2014-08-01, code: LOXO.

  • CORT

    Corcept Therapeutics Incorporated is a pharmaceutical company that conducts research, development and commercial drug treatment for people with severe metabolic and psychiatric conditions. Listed on the NASDAQ Stock Exchange in the United States, code: CORT.

  • ARMO

    ARMO BioSciences, which focuses on the development of tumor immunomodulatory preparations, was listed on the NASDAQ market on January 26, 2018 under the symbol of "ARMO".

  • Mogu Street

    Mogu Street, an e-commerce site dedicated to fashion women consumers, offers girls clothing, shoes, bags, accessories and beauty products for young women. Mogu StreetAPP has become a must-have app for fashion women to buy and share.

  • ?Huya

    Huya Inc. is a live broadcast interactive platform based on game live broadcast. It is mainly based on game live broadcast, covering entertainment, variety, education, outdoor, sports and other live content.

Partner

More  
Institutional Strategic Cooperation
  • JD Finance

    JD Finance operated independently in October 2013 and is positioned as a technology company serving financial institutions. So far, 11 business segments have been established - corporate finance, consumer finance, wealth management, payment, crowdfunding, insurance, securities, rural finance, financial technology, overseas business, and urban computing.

  • CICC

    CICC, the full name is China International Capital Corporation, was established on June 25th, 1995. It is the first Sino-foreign joint venture investment bank in Mainland China and was listed on the Main Board of the Hong Kong Stock Exchange on November 9th, 2015. CICC became the largest equity investment bank in China during the restructuring of large-scale state-owned enterprises in China. Coupled with the salary level that can be in the same league as the international investment banks, CICC is known as the "nobility of investment banks."

  • Guoxin Securities

    Guoxin Securities Co., Ltd. is a large-scale comprehensive securities company, AA-class Securities Company with a registered capital of 7 billion yuan, having 54 outlets in 38 cities across the country and currently employs 9,443 people.

  • CITIC Securities Company Limited

    CITIC Securities Company Limited (English name: CITIC Securities Company Limited) is the first batch of integrated securities companies that China Securities Regulatory Commission approved, the precursor was CITIC Securities Co., Ltd. CITIC Securities Company Limited was established in Beijing on October 25, 1995 and the registered Capital is 6,630,467,600 yuan.

Research Institute Cooperation
  • Wuhan University

    On November 27, 2018, Cornerstone Capital joined Wuhan University to built a “Global Financial Research Studio”.

  • South China University of Technology

    In 2017, School of Economics and Trade from South China University of Technology, together with Cornerstone Capital, built "International Financial Research and Practice Base" and "Financial engineering Research Center Practice Base".

  • South China Normal University

    May 26, 2017, School of Mathematical Sciences from South China Normal University and Cornerstone Capital jointly to create a "Quantitative Investment Laboratory."

Business

Cornerstone Capital's products are mainly domestic and foreign primary and secondary markets, IPO cornerstone investors, and US dollar funds,which is a diversified portfolio of cross-market, cross-cycle and cross-category.


  • Primary Market

  • Secondary Market

  • IPO Cornerstone Investment

  • Commodity Future

Products

  • The Series of Oriental Value Private Fund

    The series of Oriental Value Private Fund is the representative product of Cornerstone Capital and the first privately funded QDII fund in China focusing on Chinese stock investment. At present, the Oriental Value Private Fund and the Oriental Value Private Fund II, which have been liquidated, have achieved cumulative yields of 101.31% and 24.50% respectively, which are highly recognized by the industry.

    Detail  
  • Value Regression Series

    The Value Regression Series Fund is a private equity fund invested by Cornerstone Capital in a listed company that intends to privatize. It is mainly invested in privatized companies of US stocks, and its targets are distributed in TMT, media communications and other industries.

    Detail  
  • Unicorn Series

    The Unicorn Series Fund is a private equity QDII fund invested by Cornerstone Capital in a unicorn company. The fund invests mainly in unicorn companies in the industries of e-commerce, culture and entertainment, biomedicine, and cloud computing.

    Detail  
  • Quantitative Hedging Series

    The Quantitative Hedging Series Fund is a private equity fund that Cornerstone Capital issues through its quantitative analysis and computerized programming. The main quantitative methods used by the fund include data mining methods such as machine learning, pattern recognition, and neural networks.

    Detail  
  • The Series of Oriental Value Private Fund

    The series of Oriental Value Private Fund is the representative product of Cornerstone Capital and the first privately funded QDII fund in China focusing on Chinese stock investment. At present, the Oriental Value Private Fund and the Oriental Value Private Fund II, which have been liquidated, have achieved cumulative yields of 101.31% and 24.50% respectively, which are highly recognized by the industry.

    Detail  

News Center

More  
 

財新傳媒攜手基巖資本舉辦新經濟投資論壇

2018/12/25 12:07:23

主辦單位財新傳媒,戰略合作伙伴基巖資本

 

基巖資本榮獲“杰出私募股權投資機構”獎、“杰出私募產品”獎圖片

2018/12/25 12:06:37

金融界向基巖資本頒發了“杰出私募股權投資機構”和“杰出私募產品”兩項大獎

 

基巖資本副總裁岑賽銦現身2018私募基金高峰論壇暨金斧子廣州財富中心開業典禮

2018/8/24 10:23:49

5月19日,2018私募基金高峰論壇暨金斧子廣州財富中心開業典禮成功舉辦。國家信息中心首席經濟學家范劍平、土巴兔副總裁徐建華、清流資本創始合伙人王夢秋、凱輝資本合伙人王錚、基巖資本副總裁岑賽銦等投資圈大咖云集會場,共同探討了宏觀經濟新動態、新經濟下的股權投資新趨勢,吸引了數百名高凈值投資者現場參與。

Contact Us

  • 020-38917643
  • 020-38917643-102
  • [email protected]
  • Room 4901 Pearl River Road 6th Chow Tai Fook Financial Center, Tianhe District, Guangzhou ,Guangdong,China
? 2017- 廣州基巖資產管理有限公司 版權所有 天天酷跑啵啵奇 技術支持 www.szhzct.cn